Your browser doesn't support javascript.
loading
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
Kim, Jin Won; Lee, Yun-Gyoo; Hwang, In Gyu; Song, Hong Suk; Koh, Su Jin; Ko, Yoon Ho; Shin, Seong Hoon; Woo, In Sook; Hong, Soojung; Kim, Tae-Yong; Kim, Sun Young; Nam, Byung-Ho; Kim, Hyun Jung; Kim, Hyo Jung; Lee, Myung Ah; Kwon, Jung Hye; Hong, Yong Sang; Bae, Sung Hwa; Koo, Dong-Hoe; Kim, Kwang-Il; Kim, Jee Hyun.
Afiliación
  • Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Lee YG; Department of Internal Medicine, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Hwang IG; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea.
  • Song HS; Department of Internal Medicine, Dongsan Medical Center, Keimyung University, Daegu, South Korea.
  • Koh SJ; Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, South Korea.
  • Ko YH; Department of Internal Medicine, Uijeongbu St. Mary's Hospital, Uijeongbu, South Korea.
  • Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, South Korea.
  • Woo IS; Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Hong S; Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.
  • Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim SY; Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
  • Nam BH; Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
  • Kim HJ; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, South Korea.
  • Kim HJ; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea.
  • Lee MA; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Kwon JH; Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
  • Hong YS; Department of Oncology, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea.
  • Bae SH; Department of Internal Medicine, Daegu Catholic University Hospital, Daegu, South Korea.
  • Koo DH; Department of Internal Medicine, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Kim KI; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Kim JH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea. jhkimmd@snu.ac.kr.
Br J Cancer ; 118(9): 1169-1175, 2018 05.
Article en En | MEDLINE | ID: mdl-29576622

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cuidados Paliativos / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cuidados Paliativos / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Corea del Sur